Synthesis of pyridazinone pharmaceutical intermediates using diketene reactant
AssigneeDiamond Shamrock Corporation
InventorsRussell M. Bimber, Russell Buchman, Michael F. DePompei, Larry J. Powers
Life of this patent
Estimating the term…
Abstract
Valuable pyridazinone intermediates to pharmaceutically useful compounds can be prepared in surprisingly high yields by the reaction of the corresponding monohydrazone with diketene, preferably in the presence of a basic catalyst. In an especially preferred embodiment, p,p'-dichlorobenzil monohydrazone and diketene are reacted in a xylene solvent in the presence of triethylamine to afford 4-acetyl-5,6-bis(p-chlorophenyl)-2H-pyridazin-3-one, which can then be reacted with ethylene carbonate in the presence of potassium carbonate to afford the antihypertensive agent, 4-acetyl-5,6-bis(p-chlorophenyl)-2-(2'-hydroxyethyl)-2H-pyridazine-3-one.
Claims21
A process for the preparation of a compound of the general formula ##STR12## wherein X.sub.c and Y.sub.c are the same or different and are independently selected from the group consisting of halogen, C.sub.1 -C.sub.4 alkyl and C.sub.1 -C.sub.4 alkoxy where c is 0, 1 or 2;
- which comprises reacting a monohydrazone of the formula ##STR13## wherein X.sub.c and Y.sub.c are defined as above, with diketene.
A process for the preparation of 4-acetyl-5,6-bis(p-chlorophenyl)-2H-pyridazin-3-one which comprises reacting p,p'-dichlorobenzil monohydrazone with diketene in a suitable organic solvent at elevated temperature.
Dependencies are inferred from the claim text.